CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma

被引：0
|
作者：
Xiaobo Cai
Jun Li
Xiaodong Yuan
Jingbo Xiao
Steven Dooley
Xinjian Wan
Honglei Weng
Lungen Lu
机构：
[1] Shanghai Jiao Tong University School of Medicine,Department of Gastroenterology, Shanghai General Hospital
[2] University Medical Center Hamburg-Eppendorf,Department of Hepatobiliary and Transplant Surgery
[3] Heidelberg University,Department of Medicine II, Section Molecular Hepatology, Medical Faculty Mannheim
来源：
Journal of Translational Medicine | / 16卷
关键词：
Intrahepatic cholangiocarcinoma; CD133; Epithelial–mesenchymal transition;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] High Rab25 expression associates with Ki67/TP53/CD133/VEGFR expression predicts poor prognosis in gastric cancer
    Xiong, Jixian
    Li, Shuiming
    Zeng, Xiandong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (07): : 7792 - 7800
  • [32] CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors
    Beier, Dagmar
    Wischhusen, Joerg
    Dietmaier, Wolfgang
    Hau, Peter
    Proescholdt, Martin
    Brawanski, Alexander
    Bogdahn, Ulrich
    Beier, Christoph P.
    BRAIN PATHOLOGY, 2008, 18 (03) : 370 - 377
  • [33] Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer
    Chitra Joseph
    Maariya Arshad
    Sasagu Kurozomi
    Maryam Althobiti
    Islam M. Miligy
    Sara Al-izzi
    Michael S. Toss
    Fang Qin Goh
    Simon J. Johnston
    Stewart G. Martin
    Ian O. Ellis
    Nigel P. Mongan
    Andrew R. Green
    Emad A. Rakha
    Breast Cancer Research and Treatment, 2019, 174 : 387 - 399
  • [34] Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer
    Joseph, Chitra
    Arshad, Maariya
    Kurozomi, Sasagu
    Althobiti, Maryam
    Miligy, Islam M.
    Al-izzi, Sara
    Toss, Michael S.
    Goh, Fang Qin
    Johnston, Simon J.
    Martin, Stewart G.
    Ellis, Ian O.
    Mongan, Nigel P.
    Green, Andrew R.
    Rakha, Emad A.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (02) : 387 - 399
  • [35] Overexpression of PROM1 (CD133) confers poor prognosis in non-small cell lung cancer
    Qiu, Zhi-Xin
    Zhao, Shuang
    Mo, Xian-Ming
    Li, Wei-Min
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (06): : 6589 - U1683
  • [36] Overexpression Of Prom1 (cd133) Confers Poor Prognosis In Non-Small Cell Lung Cancer
    Qiu, Z. -X.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [37] Influence of CD133~+ expression on patients' survival and resistance of CD133~+ cells to anti-tumor reagents in gastric cancer
    De-Hu Chen
    Rui-Qi Lu
    Xiao-Chun Ni
    Ju-Gang Wu
    Shou-Lian Wang
    Bo-Jian Jiang
    Ji-Wei Yu
    Asian Pacific Journal of Tropical Biomedicine, 2015, (12) : 996 - 1004
  • [38] Expression of CD133 correlates with differentiation of human colon cancer cells
    Feng, Hai-Liang
    Liu, Yu-Qin
    Yang, Li-Juan
    Bian, Xiao-Cui
    Yang, Zhen-Li
    Gu, Bei
    Zhang, Hong
    Wang, Chun-Jing
    Su, Xiao-Ling
    Zhao, Xiao-Mei
    CANCER BIOLOGY & THERAPY, 2010, 9 (03) : 215 - 222
  • [39] CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis
    Chen, Shicai
    Song, Xinming
    Chen, Zhihui
    Li, Xinxin
    Li, Mingzhe
    Liu, Haiying
    Li, Jianchang
    PLOS ONE, 2013, 8 (02):
  • [40] CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors
    Shmelkov, Sergey V.
    Butler, Jason M.
    Hooper, Andrea T.
    Hormigo, Adilia
    Kushner, Jared
    Milde, Till
    St. Clair, Ryan
    Baljevic, Muhamed
    White, Ian
    Jin, David K.
    Chadburn, Amy
    Murphy, Andrew J.
    Valenzuela, David M.
    Gale, Nicholas W.
    Thurston, Gavin
    Yancopoulos, George D.
    D'Angelica, Michael
    Kemeny, Nancy
    Lyden, David
    Rafii, Shahin
    JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (06): : 2111 - 2120
12345